Inhibition of Melanogenesis via Passive Immune Targeted Alpha-MSH Binder Polypeptide
Authors:
- Se-Hyo JeongSJSe-Hyo Jeong
- Hun-Hwan KimHKHun-Hwan Kim
- Abigail Joy D. Rodelas-AngeliaARAbigail Joy D. Rodelas-Angelia
- Mark Rickard N. AngeliaMAMark Rickard N. Angelia
- Pritam Bhagwan BhosalePBPritam Bhagwan Bhosale
- Eun-Hye KimEKEun-Hye Kim
- Tae-Sung JungTJTae-Sung Jung
- Mee-Jung AhnMAMee-Jung Ahn
- Gon-Sup KimGon-Sup Kim
Open Access
Abstract
Alpha-melanocyte stimulating hormone (α-MSH) is a hormone that stimulates the formation of melanin, which is responsible for protecting the skin from UV rays. However, excessive production of melanin causes pigmentation, leading to skin disorders, such as melasma and freckles. Using phage display technology, we screened a modified hagfish VLRB (α-MSH target binding polypeptide) library for polypeptides that recognize α-MSH. This was expressed in E. coli to produce binding proteins that specifically bind to α-MSH. In this study, we investigated the effect of α-MSH binder protein on the inhibition of melanogenesis in B16F10 cells stimulated with α-MSH and the mechanism of inhibition. The α-MSH-induced inhibition of intracellular and extracellular melanogenesis was accompanied by the downregulation of TRP1 and TRP2, and melanogenesis-related proteins, such as tyrosinase and MITF, were significantly downregulated. These results suggest that the α-MSH binder polypeptide regulates melanogenesis inhibition and its associated mechanisms.Keywords
This publication has 32 references indexed in Scilit:
- Passive immunoprophylaxis with Ccombodies against Vibrio parahaemolyticus in Pacific white shrimp (Penaeus vannamei)Fish & Shellfish Immunology, 2024
- New opportunities and challenges of natural products research: When target identification meets single-cell multiomicsActa Pharmaceutica Sinica B, 2022
- Evolution of variable lymphocyte receptor B antibody loci in jawless vertebratesProceedings of the National Academy of Sciences, 2021
- The pharmacology and therapeutic applications of monoclonal antibodiesPharmacology Research & Perspectives, 2019
- The variable lymphocyte receptor as an antibody alternativeCurrent Opinion in Biotechnology, 2018
- Advances in targeting cell surface signalling molecules for immune modulationNature Reviews Drug Discovery, 2013
- Structure and specificity of lamprey monoclonal antibodiesProceedings of the National Academy of Sciences, 2008
- Active and passive immunity, vaccine types, excipients and licensingOccupational Medicine, 2007
- Identification of Tyrosinase Inhibitors fromGlycyrrhiza uralensisPlanta Medica, 2005
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transferBritish Journal of Dermatology, 2002